ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 29 filers reported holding ATYR PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $927,668 | -27.6% | 586,997 | -1.1% | 0.00% | – |
| Q2 2023 | $1,281,903 | +5.4% | 593,474 | +2.5% | 0.00% | – |
| Q1 2023 | $1,215,694 | +229276.2% | 578,902 | +139.0% | 0.00% | – |
| Q4 2022 | $530 | -99.9% | 242,239 | +1.1% | 0.00% | – |
| Q3 2022 | $718,000 | +6.4% | 239,496 | +0.3% | 0.00% | – |
| Q2 2022 | $675,000 | -46.1% | 238,809 | +1.9% | 0.00% | – |
| Q1 2022 | $1,253,000 | -27.5% | 234,322 | +1.2% | 0.00% | – |
| Q4 2021 | $1,729,000 | +46.3% | 231,499 | +77.7% | 0.00% | – |
| Q3 2021 | $1,182,000 | +120.9% | 130,282 | +18.7% | 0.00% | – |
| Q2 2021 | $535,000 | +99.6% | 109,761 | +82.2% | 0.00% | – |
| Q1 2021 | $268,000 | +42.6% | 60,248 | +24.0% | 0.00% | – |
| Q4 2020 | $188,000 | +27.0% | 48,598 | +5.4% | 0.00% | – |
| Q3 2020 | $148,000 | -27.5% | 46,130 | 0.0% | 0.00% | – |
| Q2 2020 | $204,000 | +466.7% | 46,130 | +253.8% | 0.00% | – |
| Q1 2020 | $36,000 | -66.7% | 13,040 | -50.0% | 0.00% | – |
| Q4 2019 | $108,000 | +140.0% | 26,080 | +100.0% | 0.00% | – |
| Q3 2019 | $45,000 | – | 13,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,626,624 | $7,310,066 | 2.43% |
| Tikvah Management LLC | 2,460,833 | $3,888,116 | 1.40% |
| TANG CAPITAL MANAGEMENT LLC | 471,134 | $744,392 | 0.10% |
| FEDERATED HERMES, INC. | 10,169,600 | $16,067,968 | 0.04% |
| Alyeska Investment Group, L.P. | 2,455,555 | $3,879,777 | 0.03% |
| XTX Topco Ltd | 73,894 | $116,753 | 0.02% |
| ALTERNA WEALTH MANAGEMENT, INC | 10,000 | $15,800 | 0.02% |
| Pale Fire Capital SE | 55,857 | $88,254 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 27,559 | $44 | 0.00% |
| Virtu Financial LLC | 13,662 | $22 | 0.00% |